Inspector General: FDA flunking clinical trials oversight

A linkurl:report;http://www.oig.hhs.gov/oei/reports/oei-01-06-00160.pdf released today by the Department of Health and Human Services reveals that the linkurl:FDA;http://www.the-scientist.com/article/display/36885/ is woefully lax in monitoring clinical trials research, according to the linkurl:New York Times.;http://www.nytimes.com/2007/09/28/health/policy/28fda.html?ref=health The article reports that agency officials don't know how many clinical trials are going, and that just 200 inspecto

By | September 28, 2007

A linkurl:report;http://www.oig.hhs.gov/oei/reports/oei-01-06-00160.pdf released today by the Department of Health and Human Services reveals that the linkurl:FDA;http://www.the-scientist.com/article/display/36885/ is woefully lax in monitoring clinical trials research, according to the linkurl:New York Times.;http://www.nytimes.com/2007/09/28/health/policy/28fda.html?ref=health The article reports that agency officials don't know how many clinical trials are going, and that just 200 inspectors oversee 350,000 trials. They audited fewer than 1 percent of all sites, generally after the trials were complete, and rarely followed up with trial sites about problems they identified. The article also notes - and illustrates with a troubling example - that the agency conducts no oversight at all over "privately funded noncommercial" trials, creating a fractured system in which patients subject to ethical abuses have little recourse.

Popular Now

  1. Major German Universities Cancel Elsevier Contracts
  2. Running on Empty
    Features Running on Empty

    Regularly taking breaks from eating—for hours or days—can trigger changes both expected, such as in metabolic dynamics and inflammation, and surprising, as in immune system function and cancer progression.

  3. Most of Human Genome Nonfunctional: Study
  4. Identifying Predatory Publishers
AAAS